Effects of Zymeboost+TM on Type II Diabetes

Report prepared by: Health Education Corporation (HEC)
CLIA #46D0914948

Using the cholestech CDX CLIA approved testing monitor, twelve individuals with type II diabetes were selected and placed into 3 groups of equal numbers. Each group ranged in age from mid 30’s to mid 60’s and consisted of two female and two male subjects. Group A, B, &C were all tested on day one approximately one hour after eating a high carbohydrate meal of 150 grams. The following is the blood sugar levels of each group respectively.

Each group was asked to follow their normal regimen of insulin intake as prescribed by their doctors. HEC then placed Group A on a placebo, Group B continued their normal regimen, and group C was placed on four (4) 250mg capsules per day of Zymeboost. One capsule with each meal and one before going to bed. After two weeks blood samples were again collected in the same manner as before.

These results were astounding in only two weeks Groups A&B showed little or no change while Group C showed a 13% reduction in blood sugar levels. On day 30 blood was drawn again in the same manner and each group average was recorded below

As you can see in just one month the people in Group C dropped an average of 18% in blood sugar levels by taking Zymeboost. HEC intends to continue its tests with and without insulin, with children under 20 and with seniors over 70. We believe this to be valuable information and when all tests are complete, submit them for publication